Browse by author
Lookup NU author(s): Dr Ethan SenORCiD
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
© The Author(s) 2026. Published by Oxford University Press on behalf of the British Society for Rheumatology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Lay Summary: What does this mean for patients? Juvenile idiopathic arthritis (JIA) is the most common type of arthritis that starts before the age of 16 years. Many children and young people (CYP) continue to be affected by JIA and may need to be on treatment when they are adults. Most CYP with JIA have swollen, stiff and painful joints for at least 6 weeks. JIA can also affect other parts of the body. This includes the skin, the places where tendons join bones (called entheses) and sometimes internal organs. Some young people may also develop inflammation in their eyes, called uveitis. If this is not treated, it can affect eyesight and could lead to sight loss. People with JIA often need medicines to control inflammation. They are usually cared for by a team of healthcare professionals called a multidisciplinary team. This team may include doctors, nurses, pharmacists, physiotherapists, occupational therapists, podiatrists, psychologists and youth workers. They work together to help manage symptoms and prevent long-term damage. The British Society for Rheumatology (BSR) is the main organisation in the UK for healthcare professionals who care for people with JIA. BSR writes guidelines that help healthcare teams provide high-quality care. These guidelines are written with input from experts and people with lived experience. They help make sure that everyone receives good care wherever they live, including during the move from child to adult services. This article explains how BSR will develop a new guideline to diagnose, treat and monitor children, young people and adults with JIA. The guideline will follow the BSR protocol for creating clinical guidelines.
Author(s): Beesley RP, Bray L, Bridges A, Chaplin H, Ciurtin C, Cleary G, Cooray S, Aragon Cuevas O, Cuthbert V, Deepak S, Earle E, Ferreira A, Kearsley-Fleet L, Gupta J, Houston R, Hum RM, Humphreys JH, Jones S, MacFadyen C, Nisbet J, Arunath V, Prior Y, Rogers V, Shoop-Worrall SJW, Solebo AL, Waller R, Williamson LD, Wilson D, Wright C, Sen ES, Roddy E, Mewar D, Kaul A, Ciurtin C, Compeyrot-Lacassagne S, Compeyrot-Lacassagne S, Kuttikat A, Williams E, Abhishek A, Joyce C, Merrison K, Dhillon E, Jones C, Rose-Parfitt E, Jayasekera H, Jayasekera H, Saha P
Publication type: Review
Publication status: Published
Journal: Rheumatology Advances in Practice
Year: 2026
Volume: 10
Issue: 2
Online publication date: 04/05/2026
Acceptance date: 19/04/2026
ISSN (electronic): 2514-1775
Publisher: Oxford University Press
URL: https://doi.org/10.1093/rap/rkag052
DOI: 10.1093/rap/rkag052
Data Access Statement: No new data were generated or analysed in support of this article.
